Literature DB >> 16020784

Ranks of genuine associations in whole-genome scans.

Dmitri V Zaykin1, Lev A Zhivotovsky.   

Abstract

With the recent advances in high-throughput genotyping techniques, it is now possible to perform whole-genome association studies to fine map causal polymorphisms underlying important traits that influence susceptibility to human diseases and efficacy of drugs. Once a genome scan is completed the results can be sorted by the association statistic value. What is the probability that true positives will be encountered among the first most associated markers? When a particular polymorphism is found associated with the trait, there is a chance that it represents either a "true" or a "false" association (TA vs. FA). Setting appropriate significance thresholds has been considered to provide assurance of sufficient odds that the associations found to be significant are genuine. However, the problem with genome scans involving thousands of markers is that the statistic values of FAs can reach quite extreme magnitudes. In such situations, the distributions corresponding to TAs and the most extreme FAs become comparable and significance thresholds tend to penalize TAs and FAs in a similar fashion. When sorting between true and false associations, the "typical" place (i.e., rank) of TAs among the most significant outcomes becomes important, ordered by the association statistic value. The distribution of ranks that we study here allows calculation of several useful quantities. In particular, it gives the number of most significant markers needed for a follow-up study to guarantee that a true association is included with certain probability. This can be calculated conditionally on having applied a multiple-testing correction. Effects of multilocus (e.g., haplotype association) tests and impact of linkage disequilibrium on the distribution of ranks associated with TAs are evaluated and can be taken into account.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16020784      PMCID: PMC1456777          DOI: 10.1534/genetics.105.044206

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  27 in total

1.  True and false positive peaks in genomewide scans: The long and the short of it.

Authors:  P Visscher; C Haley
Journal:  Genet Epidemiol       Date:  2001-05       Impact factor: 2.135

2.  Power and efficiency of the TDT and case-control design for association scans.

Authors:  Ralph McGinnis; Sagiv Shifman; Ariel Darvasi
Journal:  Behav Genet       Date:  2002-03       Impact factor: 2.805

3.  Is peak height sufficient?

Authors:  D Siegmund
Journal:  Genet Epidemiol       Date:  2001-05       Impact factor: 2.135

4.  Bounds and normalization of the composite linkage disequilibrium coefficient.

Authors:  Dmitri V Zaykin
Journal:  Genet Epidemiol       Date:  2004-11       Impact factor: 2.135

5.  Effect of two- and three-locus linkage disequilibrium on the power to detect marker/phenotype associations.

Authors:  Dahlia M Nielsen; Margaret G Ehm; Dmitri V Zaykin; Bruce S Weir
Journal:  Genetics       Date:  2004-10       Impact factor: 4.562

6.  Significance levels in complex inheritance.

Authors:  N E Morton
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

7.  Mapping mendelian factors underlying quantitative traits using RFLP linkage maps.

Authors:  E S Lander; D Botstein
Journal:  Genetics       Date:  1989-01       Impact factor: 4.562

8.  Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction.

Authors:  Kouichi Ozaki; Yozo Ohnishi; Aritoshi Iida; Akihiko Sekine; Ryo Yamada; Tatsuhiko Tsunoda; Hiroshi Sato; Hideyuki Sato; Masatsugu Hori; Yusuke Nakamura; Toshihiro Tanaka
Journal:  Nat Genet       Date:  2002-11-11       Impact factor: 38.330

9.  Large-scale association study identifies ICAM gene region as breast and prostate cancer susceptibility locus.

Authors:  Stefan Kammerer; Richard B Roth; Richard Reneland; George Marnellos; Carolyn R Hoyal; Nathan J Markward; Florian Ebner; Marion Kiechle; Ulrike Schwarz-Boeger; Lyn R Griffiths; Christian Ulbrich; Korbinian Chrobok; Gerhard Forster; Georg M Praetorius; Peter Meyer; Joachim Rehbock; Charles R Cantor; Matthew R Nelson; Andreas Braun
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

10.  Two-stage designs for gene-disease association studies.

Authors:  Jaya M Satagopan; David A Verbel; E S Venkatraman; Kenneth E Offit; Colin B Begg
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

View more
  39 in total

1.  The AVPR1A gene and substance use disorders: association, replication, and functional evidence.

Authors:  Brion S Maher; Vladimir I Vladimirov; Shawn J Latendresse; Dawn L Thiselton; Rebecca McNamee; Moonsu Kang; Tim B Bigdeli; Xiangning Chen; Brien P Riley; John M Hettema; Howard Chilcoat; Christian Heidbreder; Pierandrea Muglia; E Lenn Murrelle; Danielle M Dick; Fazil Aliev; Arpana Agrawal; Howard J Edenberg; John Kramer; John Nurnberger; Jay A Tischfield; Bernie Devlin; Robert E Ferrell; Galina P Kirillova; Ralph E Tarter; Kenneth S Kendler; Michael M Vanyukov
Journal:  Biol Psychiatry       Date:  2011-04-22       Impact factor: 13.382

2.  Critical Issues in the Inclusion of Genetic and Epigenetic Information in Prevention and Intervention Trials.

Authors:  Shawn J Latendresse; Rashelle Musci; Brion S Maher
Journal:  Prev Sci       Date:  2018-01

3.  Pathway-based approaches for analysis of genomewide association studies.

Authors:  Kai Wang; Mingyao Li; Maja Bucan
Journal:  Am J Hum Genet       Date:  2007-12       Impact factor: 11.025

4.  Flexible design for following up positive findings.

Authors:  Kai Yu; Nilanjan Chatterjee; William Wheeler; Qizhai Li; Sophia Wang; Nathaniel Rothman; Sholom Wacholder
Journal:  Am J Hum Genet       Date:  2007-08-03       Impact factor: 11.025

5.  Estimating the posterior probability that genome-wide association findings are true or false.

Authors:  József Bukszár; Joseph L McClay; Edwin J C G van den Oord
Journal:  Bioinformatics       Date:  2009-05-06       Impact factor: 6.937

6.  Probability that a two-stage genome-wide association study will detect a disease-associated snp and implications for multistage designs.

Authors:  M H Gail; R M Pfeiffer; W Wheeler; D Pee
Journal:  Ann Hum Genet       Date:  2008-07-24       Impact factor: 1.670

7.  A novel method, the Variant Impact On Linkage Effect Test (VIOLET), leads to improved identification of causal variants in linkage regions.

Authors:  Lisa J Martin; Lili Ding; Xue Zhang; Ahmed H Kissebah; Michael Olivier; D Woodrow Benson
Journal:  Eur J Hum Genet       Date:  2013-06-05       Impact factor: 4.246

8.  MAX-rank: a simple and robust genome-wide scan for case-control association studies.

Authors:  Qizhai Li; Kai Yu; Zhaohai Li; Gang Zheng
Journal:  Hum Genet       Date:  2008-05-20       Impact factor: 4.132

9.  The future is now - will the real disease gene please stand up?

Authors:  E R Martin; M A Schmidt
Journal:  Hum Hered       Date:  2008-03-31       Impact factor: 0.444

10.  Combining p-values in large-scale genomics experiments.

Authors:  Dmitri V Zaykin; Lev A Zhivotovsky; Wendy Czika; Susan Shao; Russell D Wolfinger
Journal:  Pharm Stat       Date:  2007 Jul-Sep       Impact factor: 1.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.